1.1 Articolo in rivista

1.1 Articolo in rivista: [26919] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 13.021 a 13.040 di 26.919

Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy

2017-01-01 Iori, V; Iyer, Am; Ravizza, T; Beltrame, L; Paracchini, L; Marchini, S; Cerovic, M; Hill, C; Ferrari, M; Zucchetti, M; Molteni, M; Rossetti, C; Brambilla, R; White, Hs; D'Incalci, M; Aronica, E; Vezzani, A

A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma

2012-01-01 Uboldi, S; Calura, E; Beltrame, L; Nerini, If; Marchini, S; Cavalieri, D; Erba, E; Chiorino, G; Ostano, P; D'Angelo, D; D'Incalci, M; Romualdi, C

Glutathione S-transferase activity and glutathione content in human bladder carcinoma associated with schistosomiasis: Comparison with uninvolved surrounding tissues

1997-01-01 Hassan, Aam; Tagliabue, G; Codegoni, Am; D'Incalci, M; Elsewedy, Sm; Airoldi, L

Aplidine: A new antileukemia agent active in vitro against childhood acute lymphoblastic leukemia

2001-01-01 Serafini, M; Erba, E; Gaipa, G; Tognon, G; Muradore, I; Londono, M; Faircloth, G; Jimeno, J; D'Incalci, M; Biondi, A

Unique features of trabectedin mechanism of action

2016-01-01 Larsen, Ak; Galmarini, Cm; D'Incalci, M

Antiproliferative activity and mode of action of novel compounds of marine origin

1995-01-01 Balconi, G; Erba, E; Bonfanti, M; Filippeschi, S; Garciadequesada, I; Jimeno, Jm; D'Incalci, M

High dose idarubicin and melphalan after sequential high dose chemotherapy (S-HDC) for lymphomas: Preliminary results of a phase I-II study

1999-01-01 Cocorocchio, E; Peccatori, F; Ferrucci, Pf; Cocquio, A; Agazzi, A; Corsini, C; Cinieri, S; Zucchetti, M; D'Incalci, M; Maisonneuve, P; Martinelli, G

Transfer of a human chromosomal vector from a hamster cell line to a mouse embryonic stem cell line

2007-01-01 Paulis, M; Bensi, M; Orioli, D; Mondello, C; Mazzini, G; D'Incalci, M; Falcioni, C; Radaelli, E; Erba, E; Raimondi, E; De Carli, L

Comparison of in vitro and in vivo biological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis (R) (PM00104)

2013-01-01 Romano, M; Frapolli, R; Zangarini, M; Bello, E; Porcu, L; Galmarini, Cm; Garcia-Fernandez, Lf; Cuevas, C; Allavena, P; Erba, E; D'Incalci, M

Problems in dealing with very rare adverse effects of new anticancer drugs: the example of trabectedin

2011-01-01 Grosso, F; D'Incalci, M

Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway

2009-01-01 Rizzo, A; Salvati, E; Porru, M; D'Angelo, C; Stevens, Mf; D'Incalci, M; Leonetti, C; Gilson, E; Zupi, G; Biroccio, A

p73 competes with p53 and attenuates its response in a human ovarian cancer cell line

2000-01-01 Vikhanskaya, F.; D'Incalci, M; Broggini, M.

HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR THE DETERMINATION OF PARA-(3,3-DIMETHYL-1-TRIAZENO)BENZOIC ACID IN MOUSE PLASMA

1985-01-01 Farina, P; Benfenati, E; Lassiani, L; Nisi, C; D'Incalci, M

Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies

2016-01-01 Petrillo, M; Zannoni, Gf; Beltrame, L; Martinelli, E; Difeo, A; Paracchini, L; Craparotta, I; Mannarino, L; Vizzielli, G; Scambia, G; D'Incalci, M; Romualdi, C; Marchini, S

Limbic seizures induce P-glycoprotein in rodent brain: Functional implications for pharmacoresistance

2002-01-01 Rizzi, M; Caccia, S; Guiso, G; Richichi, C; Gorter, Ja; Aronica, E; Aliprandi, M; Bagnati, R; Fanelli, R; D'Incalci, M; Samanin, R; Vezzani, A

High-performance liquid chromatographic assay for the determination of the novel C-Seco-taxane derivative (IDN 5390) in mouse plasma

2002-01-01 Zaffaroni, M; Frapolli, R; Colombo, T; Fruscio, R; Bombardelli, E; Morazzoni, P; Riva, A; D'Incalci, M; Zucchetti, M

Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein

2017-01-01 Erba, E; Romano, M; Gobbi, M; Zucchetti, M; Ferrari, M; Matteo, C; Panini, N; Colmegna, B; Caratti, G; Porcu, L; Fruscio, R; Perlangeli, Mv; Mezzanzanica, D; Lorusso, D; Raspagliesi, F; D'Incalci, M

p21 peptides linked to an internalization peptide exhibit high growth inhibition of human cancer cells

1997-01-01 Bonfanti, M; Taverna, S; Salmona, M; D'Incalci, M; Broggini, M

Contemporary pre-clinical development of anticancer agents - What are the optimal preclinical models?

2009-01-01 Damia, G; D'Incalci, M

lntratumor Heterogeneity and Its Impact on Drug Distribution and Sensitivity

2014-01-01 Nerini, If; Morosi, L; Zucchetti, M; Ballerini, A; Giavazzi, R; D'Incalci, M

Titolo	Data di pubblicazione	Autore(i)
Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy	1-gen-2017	Iori, V; Iyer, Am; Ravizza, T; Beltrame, L; Paracchini, L; Marchini, S; Cerovic, M; Hill, C; Ferrari, M; Zucchetti, M; Molteni, M; Rossetti, C; Brambilla, R; White, Hs; D'Incalci, M; Aronica, E; Vezzani, A
A Systems Biology Approach to Characterize the Regulatory Networks Leading to Trabectedin Resistance in an In Vitro Model of Myxoid Liposarcoma	1-gen-2012	Uboldi, S; Calura, E; Beltrame, L; Nerini, If; Marchini, S; Cavalieri, D; Erba, E; Chiorino, G; Ostano, P; D'Angelo, D; D'Incalci, M; Romualdi, C
Glutathione S-transferase activity and glutathione content in human bladder carcinoma associated with schistosomiasis: Comparison with uninvolved surrounding tissues	1-gen-1997	Hassan, Aam; Tagliabue, G; Codegoni, Am; D'Incalci, M; Elsewedy, Sm; Airoldi, L
Aplidine: A new antileukemia agent active in vitro against childhood acute lymphoblastic leukemia	1-gen-2001	Serafini, M; Erba, E; Gaipa, G; Tognon, G; Muradore, I; Londono, M; Faircloth, G; Jimeno, J; D'Incalci, M; Biondi, A
Unique features of trabectedin mechanism of action	1-gen-2016	Larsen, Ak; Galmarini, Cm; D'Incalci, M
Antiproliferative activity and mode of action of novel compounds of marine origin	1-gen-1995	Balconi, G; Erba, E; Bonfanti, M; Filippeschi, S; Garciadequesada, I; Jimeno, Jm; D'Incalci, M
High dose idarubicin and melphalan after sequential high dose chemotherapy (S-HDC) for lymphomas: Preliminary results of a phase I-II study	1-gen-1999	Cocorocchio, E; Peccatori, F; Ferrucci, Pf; Cocquio, A; Agazzi, A; Corsini, C; Cinieri, S; Zucchetti, M; D'Incalci, M; Maisonneuve, P; Martinelli, G
Transfer of a human chromosomal vector from a hamster cell line to a mouse embryonic stem cell line	1-gen-2007	Paulis, M; Bensi, M; Orioli, D; Mondello, C; Mazzini, G; D'Incalci, M; Falcioni, C; Radaelli, E; Erba, E; Raimondi, E; De Carli, L
Comparison of in vitro and in vivo biological effects of trabectedin, lurbinectedin (PM01183) and Zalypsis (R) (PM00104)	1-gen-2013	Romano, M; Frapolli, R; Zangarini, M; Bello, E; Porcu, L; Galmarini, Cm; Garcia-Fernandez, Lf; Cuevas, C; Allavena, P; Erba, E; D'Incalci, M
Problems in dealing with very rare adverse effects of new anticancer drugs: the example of trabectedin	1-gen-2011	Grosso, F; D'Incalci, M
Stabilization of quadruplex DNA perturbs telomere replication leading to the activation of an ATR-dependent ATM signaling pathway	1-gen-2009	Rizzo, A; Salvati, E; Porru, M; D'Angelo, C; Stevens, Mf; D'Incalci, M; Leonetti, C; Gilson, E; Zupi, G; Biroccio, A
p73 competes with p53 and attenuates its response in a human ovarian cancer cell line	1-gen-2000	Vikhanskaya, F.; D'Incalci, M; Broggini, M.
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR THE DETERMINATION OF PARA-(3,3-DIMETHYL-1-TRIAZENO)BENZOIC ACID IN MOUSE PLASMA	1-gen-1985	Farina, P; Benfenati, E; Lassiani, L; Nisi, C; D'Incalci, M
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsies	1-gen-2016	Petrillo, M; Zannoni, Gf; Beltrame, L; Martinelli, E; Difeo, A; Paracchini, L; Craparotta, I; Mannarino, L; Vizzielli, G; Scambia, G; D'Incalci, M; Romualdi, C; Marchini, S
Limbic seizures induce P-glycoprotein in rodent brain: Functional implications for pharmacoresistance	1-gen-2002	Rizzi, M; Caccia, S; Guiso, G; Richichi, C; Gorter, Ja; Aronica, E; Aliprandi, M; Bagnati, R; Fanelli, R; D'Incalci, M; Samanin, R; Vezzani, A
High-performance liquid chromatographic assay for the determination of the novel C-Seco-taxane derivative (IDN 5390) in mouse plasma	1-gen-2002	Zaffaroni, M; Frapolli, R; Colombo, T; Fruscio, R; Bombardelli, E; Morazzoni, P; Riva, A; D'Incalci, M; Zucchetti, M
Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein	1-gen-2017	Erba, E; Romano, M; Gobbi, M; Zucchetti, M; Ferrari, M; Matteo, C; Panini, N; Colmegna, B; Caratti, G; Porcu, L; Fruscio, R; Perlangeli, Mv; Mezzanzanica, D; Lorusso, D; Raspagliesi, F; D'Incalci, M
p21 peptides linked to an internalization peptide exhibit high growth inhibition of human cancer cells	1-gen-1997	Bonfanti, M; Taverna, S; Salmona, M; D'Incalci, M; Broggini, M
Contemporary pre-clinical development of anticancer agents - What are the optimal preclinical models?	1-gen-2009	Damia, G; D'Incalci, M
lntratumor Heterogeneity and Its Impact on Drug Distribution and Sensitivity	1-gen-2014	Nerini, If; Morosi, L; Zucchetti, M; Ballerini, A; Giavazzi, R; D'Incalci, M

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 13.021 a 13.040 di 26.919

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext24666
reserved1362
open891